Does Mounjaro Cancel Out Birth Control — and What Should You Do About It?

Step 1: Understand why tirzepatide affects pill absorption

When you take Mounjaro, one of its core actions is slowing the rate at which your stomach empties into the small intestine. That is largely why it reduces appetite. The same mechanism, however, means that anything you swallow (including the contraceptive pill) may spend longer in the stomach and reach the absorptive surface of the gut at a different rate than usual.

For most medicines this shift is small enough not to matter. Oral contraceptives are different. The hormones in combined and progestogen-only pills depend on consistent gut absorption to maintain the blood levels that suppress ovulation or alter cervical mucus. If absorption is reduced or delayed (especially when tirzepatide is first introduced or the dose is stepped up) there is a plausible window where pill effectiveness could be lower than expected. This is the mechanism NHS England's weight-management guidance highlights when advising on additional contraception. You can read more about tirzepatide's mechanism and licensed uses on our dedicated page.

Worth noting: the slowing of gastric emptying is most pronounced in the early weeks. As your system adjusts to a given dose, the effect on gastric transit tends to settle, which is why the four-week window is the key period.

Step 2: Know exactly what the guidance recommends, and for how long

NHS guidance is precise on this point. Women using an oral contraceptive should add a non-oral backup method for the first four weeks of Mounjaro treatment and for four weeks after each dose increase. That four-week window mirrors the period when gastric slowing is likeliest to affect pill absorption. After that window, if you remain on the same dose, the oral pill is not considered unreliable by the same mechanism.

The advisory applies every time the dose steps up: from 2.5mg to 5mg, from 5mg to 7.5mg, and so on through the titration schedule. If you are on a stable dose and have been for more than four weeks, the specific absorption concern for the pill diminishes. However, it is still sensible to discuss your contraceptive method with your prescriber at each review rather than assuming a stable dose removes all considerations. Our page on how Mounjaro affects contraceptive pills specifically covers the pill-type distinctions in more detail.

The guidance also notes that women who need reliable contraception while on Mounjaro may wish to consider switching to a method that bypasses absorption altogether, which brings us to step three.

Step 3: Choose a method that is not affected by gastric emptying

Non-oral contraceptive methods do not pass through the digestive tract, so tirzepatide's effect on gastric emptying is irrelevant to them. That covers a wide range of options: the contraceptive implant, hormonal IUDs (the coil), copper IUDs, the injectable, transdermal patches, and the vaginal ring. If you are on Mounjaro long-term and find the four-week condom rule inconvenient at every dose change, switching to one of these methods removes the concern entirely.

One quick check worth doing right now: look at the patient information leaflet that came with your contraceptive and see whether it lists medicines that delay gastric emptying as something to be aware of. Many combined pill leaflets include this category. That one-minute read can tell you whether your specific preparation flags the interaction. Our page on Mounjaro and the contraceptive implant explains why the implant is considered unaffected by this mechanism.

For a broader view of how tirzepatide interacts with other medicines and hormonal treatments, our guide to Mounjaro and birth control covers the full picture, including tirzepatide's interaction profile with various contraceptive types. NHS England's guidance on weight-management injections is the direct UK clinical source for this advisory and is worth bookmarking.

What this means when you start treatment

The practical sequence is straightforward. Before your first Mounjaro pen, tell your prescriber which contraceptive method you use. If it is an oral pill, they will advise adding a non-oral method for the first four weeks. At each dose increase, restart that four-week window. If you are on a long-acting reversible method (implant, IUD, injection) no additional precautions for contraceptive purposes are needed due to this specific interaction, though your prescriber may have other questions about your medical history.

Pregnancy is not recommended during Mounjaro treatment. Animal studies raised reproductive concerns, and the medicine's effect on developing pregnancies in humans has not been adequately studied. MHRA guidance is clear: effective contraception should be used throughout treatment. If you are planning to conceive, that is a conversation to have with your prescriber before you stop treatment, since a washout period is advised. The same applies to breastfeeding.

If you are thinking about starting treatment and want to understand how a prescriber weighs up your full contraceptive and medical history, our Mounjaro overview is a good place to start. The NHS medicines page for tirzepatide also summarises this interaction for patients in plain language. When you are ready to talk it through with a real clinician, our prescribers are available seven days a week, speak to our prescribers through a free consultation.